A comprehensive view of Combination Therapy. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

BRISTOL MYERS SQUIBB CO - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published: April 25, 2024 by SEC Edgar Filings
European Patent Office Receives Amgen Inc's Patent Application for Engineered NRG-1 Variants with Improved Selectivity Toward Erbb4 But Not Against ERBB3
Published: April 25, 2024 by Pharmaceutical Patent News
US Patent Issued to Bristol-Myers Squibb on April 23 for "Substituted bicyclic compounds useful as T cell activators" (American, Indian Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Methods and compositions for sensitization of tumor cells to immune therapy" (New York, New Jersey Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to REGENERON PHARMACEUTICALS on April 23 for "Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count